Shwe H Win

Papers

1

Total Citations

20

H-Index

1

About

Shwe H. Win is a rising voice in neurodegenerative disease research, with a focused expertise in amyotrophic lateral sclerosis (ALS) and its clinical management. In their most-cited work, a comprehensive 2023 review, Win synthesizes the current landscape of ALS therapeutics, emphasizing the critical need for multidisciplinary, collaborative care in the face of a disease that remains fatal and incurable. This paper, which has already garnered 20 citations, underscores the complex interplay of upper and lower motor neuron degeneration that culminates in respiratory failure, highlighting the urgency for innovative treatment modalities. Win’s contributions are particularly valuable for their ability to distill vast, fragmented data into actionable clinical insights, bridging the gap between emerging research and bedside practice. By mapping the future prospects of ALS therapy, Win provides a vital roadmap for both clinicians and researchers striving to improve outcomes for patients. As a researcher dedicated to one of neurology’s most challenging frontiers, Shwe H. Win is establishing a reputation for clarity, rigor, and a deep commitment to advancing care for those affected by this devastating condition.

Research Focus

Key Achievements

1
H-Index
1
Papers
20
Total Citations
20
Avg Citations/Paper
🏆 Most Cited Paper
Exploring Advancements in the Treatment of Amyotrophic Lateral Sclerosis: A Comprehensive Review of Current Modalities and Future Prospects
20 citations · 2023
📈 Most Prolific Year: 2023 (1 Papers)
🤝 Key Collaborators: 11

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago